Saluda Medical is a leader in neuromodulation therapy, dedicated to transforming chronic pain management. By focusing on advanced spinal cord stimulation technologies, the company provides innovative solutions that adapt in real-time to patients' needs. Saluda Medical's cutting-edge research and clinical trials support their commitment to improving patients' quality of life through precise and effective pain relief methodologies.
Founded: 2013
Jim Schuermann President and Chief Executive Officer |
James Erickson Chief Financial Officer |
Robert Gaffney Chief Operating Officer |
Dan Brounstein Chief Strategy Officer |
Peter Single Chief Technology Officer |
Yolanda Blasing Chief Accounting Officer |
Kristin Caplice Chief Legal Officer |
Tim Benner Chief Commercial Officer |
Steven McQuillan Chief Clinical and Regulatory Officer |